Borteshil 2mg Injection

Borteshil 2mg Injection, sold under the brand name Borteshil, is a chemotherapy medication used primarily for the treatment of multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs known as proteasome inhibitors. Bortezomib works by blocking the proteasomes inside cells, which are responsible for breaking down proteins. By inhibiting this process, bortezomib causes the accumulation of damaged proteins within the cell, leading to cell death, particularly in cancer cells, which depend on the proteasome to regulate growth and survival.

Indications: Borteshil 2mg Injection is commonly used to treat multiple myeloma (a type of blood cancer that affects plasma cells) and mantle cell lymphoma (a type of non-Hodgkin lymphoma).

• Dosage and Administration: The usual dose of bortezomib is 1.3 mg/m² of body surface area, given intravenously or subcutaneously. The exact dose and schedule depend on the patient’s condition and response to treatment.
• Mechanism of Action: As a proteasome inhibitor, bortezomib interferes with the normal folding of proteins inside cancer cells, causing them to accumulate and eventually leading to apoptosis (programmed cell death).
• Side Effects: Common side effects include nausea, diarrhea, fatigue, peripheral neuropathy (nerve damage), thrombocytopenia (low platelet count), and anemia. Less frequent but serious side effects may include infections, cardiovascular problems, and liver dysfunction.
• Administration: This medication is usually given by injection in a clinical setting, under the supervision of a healthcare professional.

• Effective Treatment for Blood Cancers: Bortezomib has shown significant efficacy in improving survival rates and managing symptoms in patients with multiple myeloma and mantle cell lymphoma.
• Combination Therapy: It is often used in combination with other chemotherapy agents, corticosteroids, or stem cell transplantation to increase its effectiveness in treating these cancers.
• Targeted Therapy: By targeting specific survival mechanisms of cancer cells, bortezomib provides a more focused treatment option than traditional chemotherapy.

Borteshil 2mg Injection is an important drug in the management of hematological cancers such as multiple myeloma and mantle cell lymphoma. Its action as a proteasome inhibitor makes it a powerful weapon in the fight against these deadly diseases, giving patients a better chance of survival and improved quality of life. However, like all cancer treatments, its side effects must be carefully monitored, and its use should be tailored to the patient’s specific needs under medical supervision.

Check this Anti Cancer product Bortezomib 2mg Injection or you may explore more Anti Cancer products by clicking here

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.